Delivery Order SPE2DB22D2206-SPE2DB24FGB22
Award Date 3/13/24
Potential Completion Date 3/14/24
Potential Value $28K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The order is for the supply of ACTIVASE 50 MG VIALS, a pharmaceutical product, with a potential value of $10,990.82 and a completion date of February 2, 2024. This delivery order is placed under Amerisourcebergen's indefinite delivery contract (IDC) with DLA, which has a potential...
- This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Activase 100 mg vials. The contract has a ceiling value of $17,141.55 and a period of performance ending on July 12, 2024. It is a firm fixed-price contract, without any set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award. As a subsidiary of...
- This is a delivery order under a prime contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the supply of 100 mg vials of the drug Activase, a critical medical product used in emergency care. The award has a ceiling value of $14,852.25 and a completion date of August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Activase 100 mg vials. The contract has a firm fixed price of $17,103.37 and a completion date of September 6, 2024. Amerisourcebergen has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- This is a $3,198.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 50 mg vials of the drug Activase. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Activase 100 mg vials. The contract has a firm fixed price and a ceiling value of $19,874.43. There is no set-aside designation for this award. AmerisourceBergen has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various agencies, including the DLA Troop Support Medical and the Department of Justice...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 50 mg vials of the pharmaceutical drug Activase (alteplase). The delivery order, valued at $7,191.80, is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 100 mg vials of Activase, a medication used for the treatment of certain medical conditions. The contract has a ceiling value of $8,338.46 and a period of performance through January 14, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $11,458.84 order is for 50 mg ACTIVASE vials, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Activase 100 mg vials. The contract has a ceiling value of $23,488.81 and a completion date of February 8, 2023. It is a firm-fixed-price contract type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...